2nd Quarter - Report

WASHINGTON HEALTH STRATEGIES GROUP for ASSOCIATION OF CLINICAL RESEARCH ORGANIZATIONS

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

21st Century Cures, Conduct of Clinical Trials, FDA, NIH, R&D Tax Credit, Corporate Tax Reform, Drug Safety, HR 6 21st Century Cures Act

LobbyistCovered position, as disclosed
SCOTT HABER —
JOHN LEWIS —
DOUGLAS PEDDICORD —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Bills named: H.R. 6 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.